Adipotrim XT by Deseo Rebajar: Recall - Undeclared Drug Ingredient
Undeclared Fluoxetine, a selective serotonin reuptake inhibitor (SSRI). Use of SSRIs have been associated with serious side effects including suicidal thinking, abnormal bleeding, and seizures. (Source: FDA MedWatch)
Source: FDA MedWatch - November 21, 2013 Category: American Health Source Type: news

My Dog Is On Prozac
Next up, DSM-5-DV; The Diagnostic and Statistical Manual of Mental Disorders-5-Doggie Version.read more (Source: Psychology Today Anxiety Center)
Source: Psychology Today Anxiety Center - November 16, 2013 Category: Psychiatry & Psychology Authors: Lawrence Rubin, Ph.D. Tags: Animal Behavior Anxiety AACAP ACCAP alex trebek allenn francis canine separation disorder. cujo DSM-5 Eli Lilly FDA fluoxetine hydrochloride jeopardy Lassie lawrence rubin marley old yeller pliva prozac reconcile sc Source Type: news

Fluoxetine and suicidal ideation in minor depression - Stone MB, Hammad TA.
[Abstract unavailable] Language: Eng... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - October 14, 2013 Category: Global & Universal Tags: Suicide and Self-Harm Source Type: news

Anorexia on Prozac
I review the arguments and evidence for and against the prescription of antidepressants in the treatment of anorexia, and describe my own experience of taking Prozac before starting weight gain and therapy.read more (Source: Psychology Today Depression Center)
Source: Psychology Today Depression Center - October 11, 2013 Category: Psychiatry & Psychology Authors: Dr Emily T. Troscianko Tags: Depression Eating Disorders Happiness Neuroscience anorexia nervosa antidepressants fluoxetine prozac recovery self-help serotonin SSRIs Source Type: news

Changing brains: why neuroscience is ending the Prozac era
The big money has moved from developing psychiatric drugs to manipulating our brain networksThe psychiatric drug age may have reached its peak. Although mind-altering medications are being prescribed in record numbers, signs of a radically new approach to understanding and treating mental illness are emerging from the deep waters of neuroscience. No longer focused on developing pills, a huge research effort is now devoted to altering the function of specific neural circuits by physical intervention in the brain.The starkest indication that drugs are increasingly being thought of as yesterday's cutting-edge comes from the l...
Source: Guardian Unlimited Science - September 21, 2013 Category: Science Authors: Vaughan Bell Tags: Mental health Medical research Drugs Neuroscience Features The Observer Source Type: news

Cognitive Therapy, Fluoxetine Against Depression RecurrenceCognitive Therapy, Fluoxetine Against Depression Recurrence
In higher-risk patients with depression who respond to cognitive therapy, continuation-phase cognitive therapy and fluoxetine were equally effective at preventing a relapse in a randomized, placebo-controlled trial. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 9, 2013 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Study examines long-term effects of continuation phase cognitive therapy on relapse rate of higher-risk depressive patients
For patients with recurrent major depressive disorder that have undergone acute phase cognitive therapy (CT), continuation phase CT (C-CT) does not appear to have greater preventive effects on relapse compared with patients taking fluoxetine (an antidepressant drug) after treatment is stopped, according to a study by Robin B. Jarrett, Ph.D., of The University of Texas Southwestern Medical Center, Dallas, and colleagues... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 4, 2013 Category: Consumer Health News Tags: Depression Source Type: news

Treating post-stroke depression with Xingnao Jieyu capsules or fluoxetine
The occurrence of post-stroke depression results from the effects of biological, psychological, and social factors, likely involving neurotransmitters, neuroendocrine effects, nerve anatomy, neurotrophic factors, neural regeneration, inflammatory reactions, and social psyche factors. Synaptotagmin promotes neurotransmitter release, regulates the transfer of synaptic vesicle to synaptic active zones, and is a key factor in information transfer among neurons. The Xingnao Jieyu capsule has been shown to effectively relieve neurologic impairments and lessen depression... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 16, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Xingnao Jieyu capsules are similar to fluoxetine for post-stroke depression
(Neural Regeneration Research) Xingnao Jieyu capsules are similar to fluoxetine for post- stroke depression. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 14, 2013 Category: Global & Universal Source Type: news

What is Prozac (fluoxetine)? What are the side effects of Prozac?
Prozac (fluoxetine) is an antidepressant belonging to the selective serotonin reuptake inhibitor (SSRI) class of drugs. Prozac is mainly used for the treatment of major depression, obsessive-compulsive disorder, and panic disorder. The medication was first introduced to the American market by Eli Lilly in 1988, and within a few years of its approval Prozac became one of the most widely prescribed antidepressants in the country. It works by blocking the absorption of the neurotransmitter serotonin in the brain... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 24, 2013 Category: Consumer Health News Tags: Depression Source Type: news

Prozac / Fluoxetine Side Effects
Prozac - generic fluoxetine - is an SSRI antidepressant medication used in the treatment of depression, bipolar disorder and other mental illnesses. Prozac side effects are wide-ranging from minor to serious. Patients taking Prozac should be aware of the potential side effects. (Source: About.com Bipolar Disorder)
Source: About.com Bipolar Disorder - June 25, 2013 Category: Psychiatry Authors: bipolar.guide at about.com Tags: health Source Type: news

The Next Step – Do I take HRT?
Hi there. I am at a little bit of a loss. I am now 43 years old, when I was 30 I was diagnosed with cervical cancer (only 5mm) however the consultant gave me 2 choices, to have another baby with the obvious risks, or go for a full radical hysterectomy. I already have 2 children, I didn’t want to risk having another and opted for surgery the next week. Surgery went without any complications, 3 days into my hospital stay my consultant said I was all clear, all very text book, however I still thought I could die and was preparing my family (not my children of course) that I may not see Christmas, it took a nurse, a few ...
Source: The Hysterectomy Association - June 24, 2013 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Your Stories cancer hrt hysterectomy Source Type: news

Symbyax Medication Profile
Symbyax is a combination of olanzapine, the active ingredient in Zyprexa, and fluoxetine, the active ingredient in Prozac. It is the first medication approved by the FDA the treatment of the depressive phase of bipolar disorder. (Source: About.com Bipolar Disorder)
Source: About.com Bipolar Disorder - June 13, 2013 Category: Psychiatry Authors: bipolar.guide at about.com Tags: health Source Type: news

Some Ideas for Handling Treatment-Resistant Bipolar Disorder
Bipolar disorder is being better understood each day. There is also ongoing research into its treatment. But successfully treating bipolar disorder can involve several medication trials, and it can take years to achieve remission. Even if remission is attained, recurrence is the rule — not the exception. It’s not uncommon for all first-line treatments to be exhausted. People in this situation may be considered by mental health professionals to be treatment-resistant. Luckily, there are treatments that can be tried when first-line, and even second-line, treatments for bipolar disorder fail. What is Treatment R...
Source: Psych Central - June 8, 2013 Category: Psychiatry Authors: Natasha Tracy Tags: Anticonvulsants Antidepressants Atypical Antipsychotics Bipolar Cognitive-Behavioral Disorders General Medications Mood Stabilizers Psychotherapy Treatment Abilify Aripiprazole Bipolar Disorder Clinicians Consensus Depakote Source Type: news

Some Ideas for Handling Treatment-Resistant Bipolar Disorder
Bipolar disorder is being better understood each day. There is also ongoing research into its treatment. But successfully treating bipolar disorder can involve several medication trials, and it can take years to achieve remission. Even if remission is attained, recurrence is the rule — not the exception. It’s not uncommon for all first-line treatments to be exhausted. People in this situation may be considered by mental health professionals to be treatment-resistant. Luckily, there are treatments that can be tried when first-line, and even second-line, treatments for bipolar disorder fail. What is Treatment R...
Source: Psych Central - June 8, 2013 Category: Psychiatry Authors: Natasha Tracy Tags: Anticonvulsants Antidepressants Atypical Antipsychotics Bipolar Cognitive-Behavioral Disorders General Medications Mood Stabilizers Psychotherapy Treatment Abilify Aripiprazole Bipolar Disorder Clinicians Consensus Depakote Source Type: news

Will OCD Medication Work for Me?
Although treatment of OCD symptoms with OCD medication such as Prozac (Fluoxetine), Zoloft (Sertraline) and Paxil (Paroxetine) or the tricyclic antidepressant Anafranil (Clomipramine) can be effective, not everyone responds to OCD medication. Let’s explore the factors that predict whether you’ll respond to OCD medication. (Source: About.com Obsessive Compulsive Disorder)
Source: About.com Obsessive Compulsive Disorder - June 5, 2013 Category: Psychiatry Tags: health Source Type: news

Antidepressants Linked to Doubling of C difficile RiskAntidepressants Linked to Doubling of C difficile Risk
Mirtazapine and fluoxetine appear to double the risk for Clostridium difficile infection, but other antidepressants show no link to an increased risk. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - May 7, 2013 Category: Psychiatry Tags: Psychiatry News Source Type: news

Antidepressants Linked to a Doubling of C difficile RiskAntidepressants Linked to a Doubling of C difficile Risk
Mirtazapine and fluoxetine appear to double the risk for Clostridium difficile infection, but other antidepressants show no link to an increased risk. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 7, 2013 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Dead student's family call for clampdown on slimming drug
Sarah Houston, 23, died after taking banned dinitrophenol (DNP), which she ordered online, alongside antidepressantsA coroner and the family of a medical student suffering from bulimia who died after taking a banned weight-loss drug bought online have called for a change in the law to further tighten the distribution of the substance, which has been blamed for other deaths.Dr Graham Mould, a forensic toxicologist, told an inquest into the death of Sarah Houston, 23, that a combination of dinitrophenol (DNP), which is banned from human consumption but is used as a chemical pesticide, and antidepressants may have been fatal....
Source: Guardian Unlimited Science - April 23, 2013 Category: Science Authors: Ben Quinn Tags: The Guardian Drugs trade Health Society UK news Internet Editorial Science World news Source Type: news

fluoxetine, Prozac, Sarafem, Prozac Weekly
Title: fluoxetine, Prozac, Sarafem, Prozac WeeklyCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 4/1/2013 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - April 1, 2013 Category: Psychiatry Source Type: news

Meta-Analysis: Adjunctive atypical antipsychotic treatment for major depressive disorder
Source: PLoS Medicine Area: News Atypical antipsychotic medications are widely prescribed for the adjunctive treatment of depression, yet little is known about their total risk-benefit profile. This meta-analysis reviewed the efficacy and safety profiles of aripiprazole, olanzapine/fluoxetine combination (OFC), quetiapine, and risperidone used for the adjunctive treatment of depression.   The study which included 14 randomised controlled trials found that:   . All four drugs had significant effects on remission, as follows: aripiprazole (odds ratio [OR], 2.01; 95% CI, 1.48-2.73), OFC (OR, 1.42; 95% ...
Source: NeLM - Mental Health - March 13, 2013 Category: Psychiatry Source Type: news

Potential Neuroprotective Response Induced By Antidepressant Drug
The production of new neurons in the adult normal cortex in response to the antidepressant, fluoxetine, is reported in a study published online in Neuropsychopharmacology. The research team, which is based at the Institute for Comprehensive Medical Science, Fujita Health University, Aichi, has previously demonstrated that neural progenitor cells exist at the surface of the adult cortex, and, moreover, that ischemia enhances the generation of new inhibitory neurons from these neural progenitor cells. These cells were accordingly named "Layer 1 Inhibitory Neuron Progenitor cells" (L1-INP)... (Source: Health News fr...
Source: Health News from Medical News Today - January 8, 2013 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news

Induction of adult cortical neurogenesis by an antidepressant
The production of new neurons in the adult normal cortex in response to the antidepressant, fluoxetine, is reported in a new study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 4, 2013 Category: Science Source Type: news

Induction of adult cortical neurogenesis by an antidepressant
(National Institute for Physiological Sciences) The production of new neurons in the adult normal cortex in response to the antidepressant, fluoxetine, is reported in a study published online this week in Neuropsychopharmacology. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 4, 2013 Category: Global & Universal Source Type: news